Quick Answer
JOHNSON & JOHNSON reported Cash and Equivalents of $19.71 billion for fiscal year 2025.
JOHNSON & JOHNSON Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $19.71B | -18.2% |
| 2024 | $24.11B | +10.3% |
| 2023 | $21.86B | +69.6% |
| 2022 | $12.89B | -11.0% |
| 2021 | $14.49B | +3.6% |
| 2020 | $13.98B | -19.2% |
| 2019 | $17.30B | -4.4% |
| 2018 | $18.11B | +1.6% |
| 2017 | $17.82B | -6.1% |
| 2016 | $18.97B | +38.2% |
| 2015 | $13.73B | -5.4% |
| 2014 | $14.52B | -30.6% |
| 2013 | $20.93B | +40.3% |
| 2012 | $14.91B | -39.2% |
| 2011 | $24.54B | +26.8% |
| 2010 | $19.36B | +22.4% |
| 2009 | $15.81B | +46.8% |
| 2008 | $10.77B | +38.6% |
| 2007 | $7.77B | +90.3% |
| 2006 | $4.08B | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.23B | -8.8% | -1.9% |
| June 30, 2025 | $18.58B | -25.3% | -51.7% |
| March 31, 2025 | $38.47B | +51.0% | +59.6% |
| December 31, 2024 | $24.11B | +10.3% | +20.6% |
| September 30, 2024 | $19.98B | +1.3% | -19.7% |
| June 30, 2024 | $24.88B | +17.4% | -2.3% |
| March 31, 2024 | $25.47B | +32.9% | +16.5% |
| December 31, 2023 | $21.86B | +69.6% | +10.8% |
- JOHNSON & JOHNSON showed a decrease of -18.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2025 period, JOHNSON & JOHNSON’s cash and equivalents has grown by 382.7% (from $4.08 billion to $19.71 billion).
- The most recent figure is from JOHNSON & JOHNSON’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: